Connect your AI

Prime Medicine PRME Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

Vertex PharmaceuticalsVRTX

-$431.9M-674%

Intellia TherapeuticsNTLA

$66.31M-29.7%

CRISPR TherapeuticsCRSP

-$410.74M-1,979%

Beam TherapeuticsBEAM

$25.27M+120%

RegenxbioRGNX

$70.59M+57.8%

Other financials

Income statement

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Prime Medicine's investing cash flow?: Prime Medicine (PRME) reported investing cash flow of $43.39M in Q1 2026.
How has Prime Medicine's investing cash flow changed year-over-year?: Prime Medicine's investing cash flow increased by 190.9% year-over-year, from -$47.74M to $43.39M.
What is the long-term trend for Prime Medicine's investing cash flow?: Over 3 years (2021 to 2024), Prime Medicine's investing cash flow has grown at a -2.4% compound annual growth rate (CAGR), from -$73.63M to $68.46M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.